Clinical Trial Update: Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ATYR1940 for safety, tolerability, and biological activity in facioscapulohumeral muscular dystrophy and limb girdle muscular dystrop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy
• Limb Girdle Muscular Dystrophy

Drugs mentioned

• ATYR1940

Snippet

Sponsor: aTyr Pharma, Inc. | Conditions: Facioscapulohumeral Muscular Dystrophy, Limb Girdle Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-22